NO. 4 THE FORUM, ST. HELIER, Y9
Market cap: $1.2B (2/10/2026)
Price: $10.50
FDA Approves Optune Pax® for the Treatment of Locally Advanced Pancreatic Cancer
Reg. FD
Announces Preliminary Full Year and Fourth Quarter 2025 Performance and Provides Company Update
Appoints Company President Frank Leonard as Chief Executive Officer
Reports Third Quarter 2025 Financial Results
Optune Lua® Receives Approval in Japan for the Treatment of Unresectable Advanced/Recurrent Non-Small Cell Lung Cancer (NSCLC)
News
Reports Second Quarter 2025 Financial Results
Q3
Q2
Q1
FY 2023
Registration Statement for Securities to be Offered to Employees
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Amended Schedule 13G - Ownership Report
S-8 POS